Governance Mankind Pharma Limited

MANKIND

INE634S01028

Pharmaceuticals

Delayed NSE India S.E. Other stock markets 10:28:36 16/03/2026 am IST			5-day change	1st Jan Change
2,098.90 ^INR	-1.87%		-2.88%	-4.35%

27/02	Mankind Pharma says tax penalty of 10.2 million rupees dropped	RE
16/02	Mankind Pharma says tax penalty of 4.6 million rupees dropped	RE

Executive Committee: Mankind Pharma Limited

Manager

Positions heldSince

Sheetal Arora

50 year

Chief Executive Officer

21/09/2007

Chanakya Juneja

Chief Tech/Sci/R&D Officer

15/11/2019

Pramod Gokhale

Chief Tech/Sci/R&D Officer

14/05/2010

Farhat Umar

Human Resources Officer

13/05/2019

Atish Majumdar

Sales & Marketing

09/11/2019

Anil Kumar

Chief Tech/Sci/R&D Officer

01/12/2011

Arjun Juneja

Chief Operating Officer

15/05/2009

Ashutosh Dhawan

57 year

Director of Finance/CFO

03/03/2016

Hitesh Kumar Jain

48 year

Compliance Officer	09/01/2025
Corporate Secretary	09/01/2025

Ravi Kumar Agrawal

Investor Relations Contact

Composition of the Board of Directors: Mankind Pharma Limited

Director

CommitteesSince

Ramesh Chand Juneja

70 year

Chairman

03/07/1991

Vijaya Sampath

72 year

Audit Committee	31/07/2020
Compensation Committee Chair	31/07/2020
Nominating Committee Chair	31/07/2020
Compensation Committee	28/10/2018
Nominating Committee	28/10/2018

Tilokchand Punamchand Ostwal

71 year

Audit Committee Chair	20/09/2018
Compensation Committee	01/01/2020
Nominating Committee	01/01/2020
Audit Committee	01/01/2020

Bharat Anand

49 year

Audit Committee	31/08/2018
Compensation Committee	31/08/2018
Nominating Committee	31/08/2018

Tilokchand P. Ostwal

71 year

Audit Committee Chair

10/01/2025

Rajeev Juneja

60 year

Director/Board Member

22/12/1992

Sheetal Arora

50 year

Director/Board Member

21/09/2007

Satish Kumar Sharma

52 year

Director/Board Member

23/09/2016

Vivek Kalra

62 year

Director/Board Member	01/08/2022
Independent Dir/Board Member	01/08/2022

Latest Appointments: Mankind Pharma Limited

06/11	Bliss GVS Pharma Limited Appoints Shreekrushna Joshi as Head - Legal as Senior Management Personnel, Effective November 6, 2025	CI
31/25/31	Mankind Pharma Limited Announces Resignation of Dr. Sanjay Koul, Chief Marketing Officer, Effective August 1, 2025	CI
18/25/18	Mankind Pharma Limited Announces Cessation of Surendra Lunia as Independent Director	CI
08/25/08	Mankind Pharma Limited Announces Executive Changes	CI
03/24/03	Mankind Pharma Limited Approves Appointment of Ashish Mittal as Company Secretary and Compliance Officer	CI
05/24/05	Mankind Pharma Limited Announces Resignation of Pradeep Chugh as Company Secretary, Effective November 30, 2024	CI
25/24/25	India's Axis Capital loses two senior investment bankers- sources	RE

More news

Former Officers and Directors: Mankind Pharma Limited

Insider

Positions held

SinceUntil

Sanjay Koul

Sales & Marketing

01/04/1998

01/08/2025

Surendra Lunia

Director/Board Member	19/02/2015	18/02/2025
Independent Dir/Board Member	19/02/2015	18/02/2025

Pradeep Chugh

Compliance Officer	23/09/2016	30/11/2024
Public Communications Contact	23/09/2016	30/11/2024
Corporate Secretary	23/09/2016	30/11/2024

Leonard Lee Kim

Director/Board Member

14/03/2016

09/05/2023

Prem Kumar Arora

Director/Board Member

28/02/2021

Sanjiv Dwarkanath Kaul

Director/Board Member

Ajay Bansal

Sales & Marketing

30/03/2010

Age distribution of managers

Parity Men Women

Male	20
Female	1

Of which Executive Committee

Male	10
Female	0

Of which Directors

Male	8
Female	1

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Mankind Pharma Limited is an India-based pharmaceutical company. It is engaged in developing, manufacturing, and marketing a range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It offers healthcare solutions for a range of healthcare needs with a portfolio that includes anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/ central nervous system, vitamins, minerals and nutrients and respiratory therapies. Its portfolio of brands includes Nurokind, Telmikind, Manforce (Rx), Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Dydroboon, Cefakind, Zenflox, Monticope, Dynaglipt, and others. Its branded product portfolio spans womenâ€™s health, fertility and critical care, with several brands in their respective therapy areas. Its subsidiaries include Lifestar Pharma Private Limited, Magnet Labs Private Limited, Jaspack Industries Private Limited, and others.

Employees

19,620

Sector

Pharmaceuticals

More about the company